These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 184960)

  • 1. Heterozygous familial hypercholesterolemia: failure of normal allele to compensate for mutant allele at a regulated genetic locus.
    Goldstein JL; Sobhani MK; Faust JR; Brown MS
    Cell; 1976 Oct; 9(2):195-203. PubMed ID: 184960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic studies in familial hypercholesterolemia. Evidence for a gene-dosage effect in vivo.
    Bilheimer DW; Stone NJ; Grundy SM
    J Clin Invest; 1979 Aug; 64(2):524-33. PubMed ID: 222811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of cholesterol synthesis by low density lipoprotein in isolated human lymphocytes. Comparison of cells from normal subjects and patients with homozygous familial hypercholesterolemia and abetalipoproteinemia.
    Ho YK; Faust JR; Bilheimer DW; Brown MS; Goldstein JL
    J Exp Med; 1977 Jun; 145(6):1531-49. PubMed ID: 194011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetics of the low density lipoprotein receptor. Diminished receptor activity in lymphocytes from heterozygotes with familial hypercholesterolemia.
    Bilheimer DW; Ho YK; Brown MS; Anderson RG; Goldstein JL
    J Clin Invest; 1978 Mar; 61(3):678-96. PubMed ID: 205553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of mutant fibroblasts in the analysis of the regulation of cholesterol metabolism in human cells.
    Brown MS; Brannan PG; Bohmfalk HA; Brunschede GY; Dana SE; Helgeson J; Goldstein JL
    J Cell Physiol; 1975 Apr; 85(2 Pt 2 Suppl 1):425-36. PubMed ID: 164479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of the low density lipoprotein receptor in regulating the content of free and esterified cholesterol in human fibroblasts.
    Brown MS; Faust JR; Goldstein JL
    J Clin Invest; 1975 Apr; 55(4):783-93. PubMed ID: 164482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterozygous familial hypercholesterolemia in children: low-density lipoprotein receptor mutational analysis and variation in the expression of plasma lipoprotein-lipid concentrations.
    Torres AL; Moorjani S; Vohl MC; Gagné C; Lamarche B; Brun LD; Lupien PJ; Després JP
    Atherosclerosis; 1996 Sep; 126(1):163-71. PubMed ID: 8879444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic heterogeneity in familial hypercholesterolemia: evidence for two different mutations affecting functions of low-density lipoprotein receptor.
    Goldstein JL; Dana SE; Brunschede GY; Brown MS
    Proc Natl Acad Sci U S A; 1975 Mar; 72(3):1092-6. PubMed ID: 236556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.
    Jensen HK
    Dan Med Bull; 2002 Nov; 49(4):318-45. PubMed ID: 12553167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Degradation of cationized low density lipoprotein and regulation of cholesterol metabolism in homozygous familial hypercholesterolemia fibroblasts.
    Basu SK; Goldstein JL; Anderson GW; Brown MS
    Proc Natl Acad Sci U S A; 1976 Sep; 73(9):3178-82. PubMed ID: 184464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction in cholesterol and low density lipoprotein synthesis after portacaval shunt surgery in a patient with homozygous familial hypercholesterolemia.
    Bilheimer DW; Goldstein JL; Grundy SM; Brown MS
    J Clin Invest; 1975 Dec; 56(6):1420-30. PubMed ID: 172531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of the familial hypercholesterolemia gene in heterozygotes: mechanism for a dominant disorder in man.
    Brown MS; Goldstein JL
    Science; 1974 Jul; 185(4145):61-3. PubMed ID: 4366052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diversity in expression of heterozygous familial hypercholesterolemia. Characterization of a unique kindred.
    Levy RA; Ostlund RE; Semenkovich CF; Witztum JL
    J Clin Invest; 1986 Jul; 78(1):96-101. PubMed ID: 3722389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intracellular cholesterol accumulation and coenzyme Q
    Suárez-Rivero JM; de la Mata M; Pavón AD; Villanueva-Paz M; Povea-Cabello S; Cotán D; Álvarez-Córdoba M; Villalón-García I; Ybot-González P; Salas JJ; Muñiz O; Cordero MD; Sánchez-Alcázar JA
    Biochim Biophys Acta Mol Basis Dis; 2018 Dec; 1864(12):3697-3713. PubMed ID: 30292637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of functional low-density lipoprotein receptor activity on lymphocytes of normal subjects and patients with familial hypercholesterolemia.
    Cuthbert JA; Lipsky PE
    Trans Assoc Am Physicians; 1988; 101():1-11. PubMed ID: 3269672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormal regulation of the LDL-R and HMG CoA reductase genes in subjects with familial hypercholesterolemia with the "French Canadian mutation".
    Yu L; Qiu S; Genest J
    Atherosclerosis; 1996 Jul; 124(1):103-17. PubMed ID: 8800498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of a mutant strain of human fibroblasts with a defect in the internalization of receptor-bound low density lipoprotein.
    Brown MS; Goldstein JL
    Cell; 1976 Dec; 9(4 PT 2):663-74. PubMed ID: 189940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. JD induced pluripotent stem cell-derived hepatocytes faithfully recapitulate the pathophysiology of familial hypercholesterolemia.
    Cayo MA; Cai J; DeLaForest A; Noto FK; Nagaoka M; Clark BS; Collery RF; Si-Tayeb K; Duncan SA
    Hepatology; 2012 Dec; 56(6):2163-71. PubMed ID: 22653811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ApoB metabolism in familial hypercholesterolemia. Inconsistencies with the LDL receptor paradigm.
    Fisher WR; Zech LA; Stacpoole PW
    Arterioscler Thromb; 1994 Apr; 14(4):501-10. PubMed ID: 8148348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Normalization of LDL receptor function by lymphocytes of patients with heterozygous familial hypercholesterolemia after treatment with plasma cholesterol lowering agents.
    Cuthbert JA; East CA; Lipsky PE
    Am J Med Sci; 1989 Sep; 298(3):152-60. PubMed ID: 2552800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.